Table of Contents
What changed
Revenue fell to NZD 1,155.1m from NZD 1,382.4m (-16.4%), yet EBITDAF rose to NZD 298.3m from NZD 210.3m (+41.8%) and operating profit climbed 62.9% to NZD 242.2m. PBT advanced 71.1% to NZD 202.4m and NPAT 71.5% to NZD 145.3m, with the effective tax rate essentially unchanged at 28.2% versus 28.4%. Operating cash flow almost doubled to NZD 224.5m (+81.8%) and free cash flow reached NZD 214.7m against capex of NZD 23.6m. Cash rose to NZD 114.0m, gross borrowings edged down to NZD 1,433.5m, and equity expanded to NZD 2,801.5m from NZD 2,081.5m. The interim dividend was lifted 0.1cps to 8.80cps.
What matters
- Margin expansion, not volume growth, drove the result. EBITDAF margin widened from 15.2% to 25.8% as revenue contracted 16.4%. PBT and NPAT grew in lockstep (71.1% vs 71.5%) with no tax distortion and no disclosed discontinued items, so the profit read is clean.
- Leverage improved sharply. Net debt fell to about NZD 1,319.5m and net debt/EBITDAF compressed to 4.4x from 6.5x, a material re-rating of the balance-sheet trajectory even before any full-year earnings uplift is annualised.
- Working capital stretched. Inventory days rose to 37.2 from 24.2 and receivable days to 29.6 from 23.3, lifting operating working capital by NZD 63.4m to NZD 424.2m. The build sits alongside, rather than against, the stronger cash outturn this half but is worth monitoring into 2H.
Expectations
No forward earnings guidance or stated targets were supplied. Against FY22 seasonality, the base period (HY22) delivered 48.8% of FY22 revenue, 47.8% of FY22 EBITDAF and only 38.2% of FY22 NPAT — a second-half-weighted shape, particularly on NPAT. Simply annualising HY23 revenue gives NZD 2,310.2m (about 81.5% of FY22), while HY23 EBITDAF alone already recovers 67.7% of FY22's NZD 440.3m. If the 2H traditionally carries the heavier earnings share, the release supports, but does not guarantee, material year-on-year FY23 profit growth; it does not speak to whether the HY23 margin step-up persists.
Quality of result
The earnings uplift looks substantive: stable tax rate, no discontinued-operation or one-off disclosures, and cash backing that improved rather than deteriorated. Cash conversion rose to 75.3% of EBITDAF from 58.7%, and FCF at NZD 214.7m covered NPAT 1.5x and the interim dividend comfortably (FCF payout ratio 43.0% versus 59.5%). Capex stayed modest at 2.0% of revenue. The main quality caveats are the working-capital build — especially the inventory days jump — and the fact that margin, not volume, delivered the result, which ties durability to whatever commodity, hedging or cost dynamic produced the margin step-up rather than to sustained demand.
Unresolved
- What specifically drove the 10.6 percentage point EBITDAF margin expansion on materially lower revenue — wholesale pricing, hedging timing, fuel mix, or customer book dynamics — and how much is repeatable?
- Why did inventory build NZD 52.3m (+28.4%) and what is the read-through for 2H cash flow if those stocks are drawn down at different prices?
- Equity rose NZD 720.0m while retained earnings alone cannot explain the move; the composition (hedge reserves, revaluations, equity issuance) is not disclosed in the supplied excerpts.
- No FY23 guidance, forward-work metric, or capex programme detail was provided.
This briefing cannot assess the underlying wholesale, retail or fuel-segment drivers behind the margin shift, nor management's forward outlook, because segment detail and guidance were not in the supplied data.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $1155.1m | $1382.4m | -16.4% ↓ |
| Net profit after tax | $145.3m | $84.7m | +71.5% ↑ |
| Net cash inflow from operating activities | $224.5m | $123.5m | +81.8% ↑ |
| Interim dividend per share | 8.8c | 8.7c | +1.1% ↑ |
| EBITDAF | $298.3m | $210.3m | +41.8% ↑ |
| Operating profit | $242.2m | $148.7m | +62.9% ↑ |
| Profit before tax | $202.4m | $118.3m | +71.1% ↑ |
| Cash and cash equivalents | $114m | $71.6m | +59.2% ↑ |
| Total assets | $5701.8m | $4797.9m | +18.8% ↑ |
Reference: annolyse.ai/briefings/gne-hy23
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| PBT growth | +71.1% | — | — |
| Effective tax rate | 28.2% | 28.4% | — |
| OCF / EBITDAF (cash conversion) | 75.3% | 58.7% | stable |
| FCF pre-lease | $214.7m | $152.4m | +$62.3m |
| FCF / NPAT | 147.8% | 179.9% | complementary conversion metric |
| Capex % revenue | 2.0% | 1.7% | — |
| Capex | −$23.6m | $24.0m | −$47.6m |
| Free cash flow | $214.7m | $152.4m | +$62.3m |
| Debtor days | 29.6 | 23.3 | +6.3 days |
| Inventory days | 37.2 | 24.2 | +13.0 days |
| Operating working capital | $424.2m | $360.8m | +$63.4m absorbed |
| Trade debtors | $187.9m | $176.8m | +$11.1m |
| Net debt | $1319.5m | $1374.3m | −$54.8m |
| Net debt / EBITDAF | 4.40x | 6.50x | Strengthening |
| Gross borrowings | $1433.5m | $1445.9m | −$12.4m |
| Payout ratio vs NPAT | 63.6% | — | — |
| Payout ratio vs FCF pre-lease | 43.0% | — | covered |
| ROE (annualised) | 5.2% | 4.1% | Strengthening |
| HY22 share of FY22 revenue | 48.8% | — | Other half was 51.2% |
| HY22 share of FY22 EBITDAF | 47.8% | — | Other half was 52.2% |
| HY22 share of FY22 NPAT | 38.2% | — | Other half was 61.8% |
| Profit from continuing operations | $145.3m | — | — |
Reference: annolyse.ai/briefings/gne-hy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.